Every call, accounted for.

Hypothesis: weekend coverage reinforcing the beat-and-raise and supply-constrained demand narrative may support follow-through buying. Risk: results are already several sessions old and likely priced in; coverage questions valuation and chip-equipment stocks have been selling off on AI-infrastructure concerns.

Technology · earnings · solid

1. What ASML Holding (ENXTAM:ASML)'s Record Q3 Earnings Means For ShareholdersYahoo Finance RSS · 17 Oct, 05:21 CEST
2. ASML (ASML) Says It Cannot Meet Demand Until 2028. Is the Stock Priced for That?Yahoo Finance RSS · 18 Oct, 16:31 CEST
3. ASML is the Most Important Company in the AI Ecosystem, and It Just Delivered Record Results. Here’s Where the Stock Will Be in 2028Yahoo Finance RSS · 18 Oct, 18:52 CEST

Hypothesis: strong pre-announced Q3 indicators plus a Gulf risk premium on oil and refining margins may keep energy bid. Risk: the trading statement dates from Oct 15 and is largely priced; any geopolitical de-escalation or oil-price reversal could hit the stock.

Energy · earnings · solid

1. TotalEnergies SE: Third Quarter 2026: Main IndicatorsYahoo Finance RSS · 15 Oct, 08:00 CEST
2. TotalEnergies sees Q3 European refining margin nearly 4x year earlierYahoo Finance RSS · 15 Oct, 09:06 CEST
3. TotalEnergies (ENXTPA:TTE) Flags Record Q3 Production And LNG Driven Profit UpswingYahoo Finance RSS · 15 Oct, 23:11 CEST
4. TotalEnergies Eyes Massive Profit Windfall as Refining Margins SoarYahoo Finance RSS · 15 Oct, 12:30 CEST
5. Iran says it has a 'new operational plan' if the U.S. resumes attacks, as shipping vessels report strikesCNBC world · 18 Oct, 15:52 CEST

Hypothesis: pipeline-expansion coverage and a lagging share price (down over 8% YTD per one source) could attract buyers. Risk: follow-up reporting stresses only a small part of the headline value is guaranteed, and the deal is not near-term revenue; weak link to next-session moves.

Healthcare · other · wild card

1. AstraZeneca and insitro forge $1.5bn AI-powered cardiometabolic partnershipYahoo Finance RSS · 16 Oct, 13:24 CEST
2. AstraZeneca (LSE:AZN) Enters AI Drug Discovery Partnership In MASH And CardiomyopathiesYahoo Finance RSS · 15 Oct, 21:09 CEST
3. Stocktwits Biotech Dealmaker: Gilead, AstraZeneca And Roche Chase Pipeline Expansion Over BuyoutsYahoo Finance RSS · 17 Oct, 01:57 CEST

Hypothesis: fresh weekend regulatory headline may weigh on sentiment at the open. Risk: allegations are not liability findings, financial impact is unclear, and the Friday JPMorgan upgrade to Overweight (target CHF 100) and Mexico investment news could dominate.

Consumer · other · wild card

1. Nestle, Unilever face regulatory action in India over misleading health claimsYahoo Finance RSS · 18 Oct, 10:10 CEST
2. Nestlé sued in Texas over arsenic, lead in baby foodYahoo Finance RSS · 15 Oct, 16:13 CEST

Hypothesis: order flow and a regulatory tailwind for the space JV may support the shares. Risk: reports that the FAA is nearing approval of Boeing's competing 737 MAX 10 and Cathay Pacific wide-body talks involving Boeing could offset; the JV fast-track is Bloomberg-sourced reporting, not a decision.

Aerospace · other · wild card

1. Aviation Capital Group Grows Portfolio with Order for 75 Airbus A320neo Family Aircraft, the Largest Order in ACG's HistoryYahoo Finance RSS · 16 Oct, 09:00 CEST
2. EU plans to fast-track antitrust approval of SpaceX rivalYahoo Finance RSS · 15 Oct, 20:31 CEST
3. SPCX Stock Down For Third Straight Session: The European Union Is Preparing To Fast Track Approvals For SpaceX's Satellite RivalYahoo Finance RSS · 16 Oct, 00:38 CEST

For the October 20 session, the documented preorder-demand follow-up chain could support sentiment. This is an uncertain hypothesis: sell-outs can reflect constrained supply, do not establish revenue upside, and may already be priced in. Confidence is an uncalibrated judgement.

Technology · other · solid

1. iPhone Duo Preorders Sell Out Rapidly As Delivery Estimates Slip Into JanuaryYahoo Finance RSS · 18 Oct, 15:12 CEST

For the October 20 session, the linked preliminary-refining-outlook coverage and reported shipping risk could sustain earnings optimism. This is an uncertain hypothesis, not realized profit or a new oil quote. Principal risk: de-escalation or weaker oil reverses an already strong share-price move. Confidence is an uncalibrated judgement.

Energy · filing · solid

1. ExxonMobil Flags a $4.5 Billion Refining Boost. Is the Stock Already Pricing It In?Yahoo Finance RSS · 17 Oct, 07:48 CEST
2. Oil Topped $110 as Tech Stocks Lost $1 Trillion in a DayYahoo Finance RSS · 17 Oct, 14:45 CEST
3. Iran says it has a 'new operational plan' if the U.S. resumes attacks, as shipping vessels report strikesCNBC world · 18 Oct, 15:52 CEST

For the October 20 session, follow-up attention to the panel recommendation could support sentiment about European commercial prospects. This is an uncertain hypothesis, not an approval or sales forecast. Principal risk: the recommendation is already priced in and formal approval or commercialization disappoints. Confidence is an uncalibrated judgement.

Healthcare · other · solid

1. European Union Regulators Recommend Approval For Eli Lilly Weight Loss PillYahoo Finance RSS · 18 Oct, 15:30 CEST
2. Is Novo Nordisk (CPSE:NOVO B) Facing A Bigger Threat In Europe?Yahoo Finance RSS · 18 Oct, 18:13 CEST

For the October 20 session, continued scrutiny of the reported delay could pressure expectations for launch revenue. This is an uncertain hypothesis; the supplied summaries do not quantify lost revenue. Principal risk: the reported near-7% sell-off already discounts the delay and bullish analyst views fuel a rebound. Confidence is an uncalibrated judgement.

Aerospace · other · wild card

1. Rocket Lab's Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027Yahoo Finance RSS · 17 Oct, 18:05 CEST
2. Jim Cramer says it's a 'great opportunity to sell' RKLB stockYahoo Finance RSS · 17 Oct, 17:17 CEST
3. Rocket Lab Drops 6% as Citizens Cuts Target Over Neutron Delay; Planet Labs Slides 5%, SpaceX SlipsYahoo Finance RSS · 16 Oct, 18:51 CEST

For the October 20 session, follow-up coverage could keep oncology-development risk in focus. This is an uncertain continuation hypothesis about older news, not a new trial result or proof the program has failed. Principal risk: the earlier decline already discounts the endpoint miss and continuing overall-survival evaluation supports sentiment. Confidence is an uncalibrated judgement.

Biotechnology · clinical · wild card

1. Trial Miss Might Change The Case For Investing In BioNTech Stock (BNTX)Yahoo Finance RSS · 17 Oct, 10:11 CEST
2. BioNTech (BNTX) Is Down 7.0% After mRNA Cancer Trial Misses PFS Goal Has The Bull Case Changed?Yahoo Finance RSS · 14 Oct, 05:22 CEST
3. BioNTech stock falls after cancer trial misses key endpointYahoo Finance RSS · 13 Oct, 14:19 CEST

The company trading-statement feed and reports of stronger refining margins support a near-term earnings tailwind. Sunday shipping-strike headlines may keep energy risk premia elevated into Monday. This is an intraday continuation hypothesis, not a forecast of the oil price. Much of the company update was already public on Thursday; de-escalation or profit-taking can reverse it.

Energy · earnings · solid

1. TotalEnergies SE: Third Quarter 2026: Main IndicatorsYahoo Finance RSS · 15 Oct, 08:00 CEST
2. TotalEnergies sees Q3 European refining margin nearly 4x year earlierYahoo Finance RSS · 15 Oct, 09:06 CEST
3. Iran says it has a 'new operational plan' if the U.S. resumes attacks, as shipping vessels report strikesCNBC world · 18 Oct, 15:52 CEST

Locked 18 Oct, 20:49 CEST
SHA-256 c89302a84a102405de2fb639341dc19a1e91c54d08f3287227f3bf2b822eac53

The announced aircraft order gives a concrete backlog-demand signal that may support Airbus relative to a nervous broader market. The cited company release is more specific than a general sector narrative. Execution constraints and competing Boeing approval headlines are clear contrary signals; Friday trading may already have absorbed the order.

Aerospace · company announcement · solid

1. Aviation Capital Group Grows Portfolio with Order for 75 Airbus A320neo Family Aircraft, the Largest Order in ACG's HistoryYahoo Finance RSS · 16 Oct, 09:00 CEST
2. FAA nears approval for Boeing 737 MAX 10 jetliner - reportsYahoo Finance RSS · 16 Oct, 22:26 CEST

Locked 18 Oct, 20:49 CEST
SHA-256 c89302a84a102405de2fb639341dc19a1e91c54d08f3287227f3bf2b822eac53

A fresh regulatory headline can revive reputational and compliance concerns after the separate reported baby-food litigation. This is a hypothesis about headline pressure during the next session, not an assertion that liability has been established. A recent JPMorgan upgrade is a material contrary signal and could outweigh the concerns.

Consumer · regulatory · solid

1. Nestle, Unilever face regulatory action in India over misleading health claimsYahoo Finance RSS · 18 Oct, 10:10 CEST
2. Nestlé sued in Texas over arsenic, lead in baby foodYahoo Finance RSS · 15 Oct, 16:13 CEST
3. Nestle upgraded at JPMorgan as FY27 is shaping up as a ’vintage year’Yahoo Finance RSS · 16 Oct, 12:28 CEST

Locked 18 Oct, 20:49 CEST
SHA-256 c89302a84a102405de2fb639341dc19a1e91c54d08f3287227f3bf2b822eac53

The supplied headlines contrast record results and demand extending beyond available supply with a reported 8.9% decline. That tension offers a possible relief rebound if investors reappraise earnings evidence. It is a wild card because the sector sell-off and valuation concerns can continue; multi-year demand does not establish a one-day return.

Technology · earnings · wild card

1. ASML is the Most Important Company in the AI Ecosystem, and It Just Delivered Record Results. Here’s Where the Stock Will Be in 2028Yahoo Finance RSS · 18 Oct, 18:52 CEST
2. ASML (ASML) Says It Cannot Meet Demand Until 2028. Is the Stock Priced for That?Yahoo Finance RSS · 18 Oct, 16:31 CEST
3. What ASML Holding (ENXTAM:ASML)'s Record Q3 Earnings Means For ShareholdersYahoo Finance RSS · 17 Oct, 05:21 CEST
4. ASML (ASML) Declines 8.9% Despite Dominant Moat in EUV Lithography TechnologyYahoo Finance RSS · 16 Oct, 17:25 CEST

Locked 18 Oct, 20:49 CEST
SHA-256 c89302a84a102405de2fb639341dc19a1e91c54d08f3287227f3bf2b822eac53

The announcement and later coverage create a concrete discovery-partnership chain that may support pipeline sentiment. The deal headline has contingent value, with coverage stressing that only a small portion is guaranteed. This is an early-stage research collaboration, not proof of clinical efficacy; a positive intraday response is uncertain and the news is several days old.

Healthcare · clinical partnership · wild card

1. insitro Announces a Strategic Collaboration with AstraZeneca for AI-enabled Discovery of Novel Therapeutics for MASH and CardiomyopathiesYahoo Finance RSS · 15 Oct, 12:00 CEST
2. AstraZeneca Signs AI Drug-Discovery Deal Worth Up to $1.5 Billion. Only $40 Million Is GuaranteedYahoo Finance RSS · 15 Oct, 13:32 CEST
3. AstraZeneca and insitro forge $1.5bn AI-powered cardiometabolic partnershipYahoo Finance RSS · 16 Oct, 13:24 CEST

Locked 18 Oct, 20:49 CEST
SHA-256 c89302a84a102405de2fb639341dc19a1e91c54d08f3287227f3bf2b822eac53

The preorder and delivery headlines are a near-term demand signal that can support sentiment before the next US session. A sell-out can also reflect constrained supply rather than exceptional unit demand. The cited reporting is headline-level evidence, and a record-price starting point plus broad technology selling can overpower the product narrative.

Technology · product demand · solid

1. iPhone Duo Preorders Sell Out Rapidly As Delivery Estimates Slip Into JanuaryYahoo Finance RSS · 18 Oct, 15:12 CEST
2. Apple’s $1,999 Foldable iPhone Sold Out in Minutes. Deliveries Now Slip to JanuaryYahoo Finance RSS · 17 Oct, 16:50 CEST
3. Apple Hit a Record Close Ahead of Its November 2 Report. Here’s What Charging for Extra Siri AI Could Mean for the StockYahoo Finance RSS · 17 Oct, 16:48 CEST

Locked 18 Oct, 20:49 CEST
SHA-256 8d56b036ac715b3e17d663ea838e61c382a57be3d34b392b22054e59998f8310

The combination of refinery-earnings coverage and continuing shipping disruption provides a plausible support channel for an integrated oil producer. This is not a claim that Exxon directly benefits from every disruption: operational risk and government intervention can offset a higher risk premium. A reversal in crude prices after earlier gains is the principal contrary signal.

Energy · geopolitical · solid

1. ExxonMobil Signals Massive Profit Boost From Rising Refining MarginsYahoo Finance RSS · 18 Oct, 15:01 CEST
2. Iran says it has a 'new operational plan' if the U.S. resumes attacks, as shipping vessels report strikesCNBC world · 18 Oct, 15:52 CEST
3. ExxonMobil Is Up 49% in 2026 With Brent Near $110. Here’s What the Stock Could Be Worth When Oil CoolsYahoo Finance RSS · 17 Oct, 16:14 CEST

Locked 18 Oct, 20:49 CEST
SHA-256 8d56b036ac715b3e17d663ea838e61c382a57be3d34b392b22054e59998f8310

The weekend borrowing-cost warning may renew concerns about credit demand and future credit losses during a risk-sensitive session. Higher rates can also lift bank interest income, so the signal is not one-way. The estimate is a modest downside hypothesis; existing valuation discounts and recent earnings information could instead attract buyers.

Financials · macro · solid

1. As borrowing costs spike, Jamie Dimon asks corporate America: 'Are you prepared?' You should ask yourself the same thingYahoo Finance RSS · 18 Oct, 12:40 CEST
2. What Does JPMorgan Chase (JPM) Face If Jamie Dimon Is Right On Rates?Yahoo Finance RSS · 18 Oct, 11:15 CEST
3. Is JPMorgan Chase Stock a Buy 8% Below Its Record High?Yahoo Finance RSS · 18 Oct, 09:35 CEST

Locked 18 Oct, 20:49 CEST
SHA-256 8d56b036ac715b3e17d663ea838e61c382a57be3d34b392b22054e59998f8310

Renewed direct-to-mobile competition coverage could weigh on the valuation of incumbent wireless operators, including Verizon. The cited companion article describes major network-building challenges, which weakens the immediate threat. This is a speculative headline-pressure call, not evidence that Verizon has already lost customers or revenue.

Telecom · competitor · wild card

1. SpaceX Is Buying Airwaves to Take On the Wireless Carriers. Is the Stock a Buy?Yahoo Finance RSS · 18 Oct, 16:43 CEST
2. SpaceX Faces Major Challenges Building Mobile Network After Spectrum PurchaseYahoo Finance RSS · 18 Oct, 15:22 CEST
3. Verizon launches generous customer perks after raising pricesYahoo Finance RSS · 18 Oct, 17:33 CEST

Locked 18 Oct, 20:49 CEST
SHA-256 8d56b036ac715b3e17d663ea838e61c382a57be3d34b392b22054e59998f8310

Index-inclusion coverage can attract investor attention and possible passive-flow discussion around the next session. The source does not establish future net fund flows or their timing, and the inclusion may already be priced. Competing mRNA-pipeline coverage is a contrary signal. Treat the larger estimated move as a volatile research hypothesis, not a clinical-trial conclusion.

Biotechnology · index inclusion · wild card

1. Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.Yahoo Finance RSS · 18 Oct, 15:05 CEST
2. Move Aside, Moderna: This mRNA Stock Is Sitting on a Cash Pile and a Deep Cancer PipelineYahoo Finance RSS · 17 Oct, 18:43 CEST

Locked 18 Oct, 20:49 CEST
SHA-256 8d56b036ac715b3e17d663ea838e61c382a57be3d34b392b22054e59998f8310